The Simplify Private Credit Strategy ETF (PCR) provides investors with institutional-grade private credit exposure through an ETF, yielding 11.48% as of May 31, 2026. Unlike traditional corporate bonds, PCR invests in business development companies and closed-end funds holding floating-rate senior secured loans, which adjust to interest rate changes, reducing sensitivity to Federal Reserve policies. This structure allows PCR to capture higher yields and mitigate duration risk, making it attractive for income-focused investors seeking resilience in a higher-for-longer interest rate environment. PCR uses total return swaps linked to the VettaFi Private Credit Index to achieve its goals, offering liquidity and cost efficiency uncommon in private credit investments.
CRCAM Alpes Provence has published its financial report as of June 30, 2026. The document is accessible on their official website and has been submitted to the French financial regulator, the Autorité des Marchés Financiers. This release ensures tran...
Between July 20 and July 24, 2026, Capgemini executed a buyback of 68,613 of its own shares at an average price of €91.59 per share. This transaction is part of the company's ongoing efforts to manage its capital structure and potentially enhance sha...
Commvault Systems reported strong Q1 2026 results, surpassing earnings per share and revenue estimates with EPS of $1.42 and revenue of $314.13 million. Subscription-based services drove growth, with subscription ARR up 22% to $1.05 billion and SaaS ...
Visa Inc. is set to report strong year-over-year growth in earnings per share and revenue, with analysts optimistic and maintaining Buy ratings. The company forecasts earnings of $3.23 per share on $11.40 billion revenue, up from $2.98 per share and ...
Block & Leviton LLP is investigating T1 Energy for potential securities law violations following the company's announcement of a 20% increase in capital expenditures and delays in its solar-cell project. The investigation centers on whether T1 Energy...
